180 usd

Levitee Labs Completes Acquisition of Earth Circle Organics, Adds Superfoods Company to Portfolio

  • Acquisition adds 180+ SKUs across three brands to the Levitee portfolio: Earth Circle Organics, Earth Shift Products, and Ojio
  • Combined, the three brands generated over USD $2.0M in revenue in the past 12 months, with USD $600,000 in EBITDA
  • Levitee plans to integrate the Earth Circle Organics brands with its MONKE Nutraceuticals products to leverage supply chain and distribution synergies and accelerate growth by increasing ad spend and inventory levels

Levitee Labs Inc. (CSE: LVT) (the " Company " or " Levitee "), an integrative wellness company with a diversified portfolio of healthcare and wellness assets, is pleased to announce that it has completed the acquisition of all the issued and outstanding shares of Earth Circle Organics Chain Inc. (" Earth Circle Organics ") as of August 3, 2021.

Headquartered in Las Vegas, Nevada, Earth Circle Organics is a direct-to-consumer (DTC) and wholesaler of supplements and superfood products. Earth Circle Organics sells it products primarily in the United States, but it also has a presence in Canada. Earth Circle Organics sells a robust portfolio of organic products, including Ayurvedics, nuts, seeds, berries, coconut oil, premium Himalayan pink salt, chlorella powder, fulvic acid, Nori seaweed, and much more, through multiple distribution channels. Many Earth Circle Organics products sold on Amazon.com consistently are rated 4.5-5.0 stars across thousands of aggregate consumer ratings.

With more than 180 SKUs across three brands ( Earth Circle Organics , Earth Shift Products and Ojio ), Earth Circle Organics has achieved over USD $2.0M in revenue in the past 12 months, with approximately USD $600,000 in EBITDA. 1

Levitee plans to integrate the Earth Circle Organics brands with the Company's MONKE Nutraceuticals products to leverage supply chain and distribution synergies and accelerate growth by increasing ad spend and inventory levels. Levitee intends to finalize new distribution agreements that will place all the brands in additional brick-and-mortar retail stores across the U.S. and Canada.

"We are very pleased to close the acquisition of our sixth cash flowing asset. The Earth Circle Organics portfolio of brands fits perfectly into our model as a vertically integrated wellness company with operations and distribution networks throughout North America," commented Pouya Farmand, Chief Executive Officer at Levitee. "Work has already begun in collaboration with the existing Earth Circle Organics management team on transitioning the products under our umbrella and leveraging synergies to implement aggressive growth initiatives in the vertical."

"I'm excited and proud to announce we have been acquired and are now part of the Levitee Labs family. When I first met the team at Levitee what struck me the most was how passionate and knowledgeable they were about our industry, and the calibre of industry experts they have on their team. I know Earth Circle Organics is in good hands. I'm looking forward to seeing the direction and growth they take the brand," commented John Ward, Owner of Earth Circle Organics.

In consideration for the acquisition of Earth Circle Organics, Levitee issued 488,702 shares at a deemed value of CAD $0.51 per share and paid USD $1,675,000 in cash on closing, with an additional USD $125,000 having been previously paid as a deposit. The Company may also be required to pay up to an additional USD $500,000 pursuant to an earn out mechanism based on gross revenue generated by Earth Circle Organics in the six months following closing.

The previous co-owner of Earth Circle Organics, John Ward, has agreed to continue to run the operations of Earth Circle Organics for a period of six months after closing to ensure continuous business operations and a smooth transfer of Earth Circle Organics' business to Levitee.

About Earth Circle Organics Chain

Earth Circle Organics is a direct-to-consumer and wholesaler of supplements and superfood products in North America. Earth Circle Organics has a robust portfolio of organic products, including Ayurvedics, nuts, seeds, berries, coconut oil, premium Himalayan pink salt, chlorella powder, fulvic acid, Nori seaweed, and much more, totaling over 180 SKUs. Earth Circle Organics products can be found at www.earthcircleorganicswholesale.com and www.earthshiftproducts.com.

About Levitee Labs

Levitee Labs is establishing itself as a leader in the integrative wellness space. Through leveraging an M&A regimen that focuses on the centralization of complementary integrative wellness assets, Levitee Labs aims to transform mental health and addiction treatments through the integration of psychedelic medicines and therapies.

Further information about the Company is available on its website at www.leviteelabs.com .

Forward-Looking Statements

This news release contains certain statements that may constitute forward-looking information under applicable securities laws. All statements, other than those of historical fact, which address activities, events, outcomes, results, developments, performance, or achievements that Levitee anticipates or expects may or will occur in the future (in whole or in part) should be considered forward-looking information. Such information may involve, but is not limited to, statements respecting the integration of Earth Circle Organics' products with Levitee's existing portfolio; the expected benefits and synergies created from the acquisition of Earth Circle Organics; expected revenues and financial performance of Earth Circle Organics; the expected growth of Earth Circle Organics and MONKE Nutraceuticals; Levitee's ability to place its products in brick-and-mortar retail stores; the Company's planned acquisitions, and the expected benefits of same; and Levitee's business plans and proposed products. Forward-looking information is based on currently available competitive, financial and economic data and operating plans, strategies or beliefs as of the date of this news release, but involve known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, performance or achievements of Levitee to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information. These risks and uncertainties include, but are not limited to, those identified and reported in the Company's public filings under the Company's SEDAR profile at www.sedar.com . Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that any such statements will prove to be correct. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward-looking statements or otherwise. Any and all forward-looking information contained in this press release is expressly qualified by this cautionary statement.

The CSE (operated by CNSX Markets Inc.) has neither approved nor disapproved of the contents of this press release.

For further information about Levitee, please contact:

Levitee Media Contact

media@leviteelabs.com

Levitee Investor and Corporate Communications

ir@leviteelabs.com

1 Earnings before interest, taxes, depreciation, and amortization (" EBITDA ") is a Non-GAAP measure. EBITDA should not be construed as alternatives to net income/loss determined in accordance with International Financial Reporting Standards (" IFRS "). EBITDA does not have any standardized meaning under IFRS and therefore may not be comparable to similar measures presented by other issuers. The Company believes that EBITDA is a meaningful financial metric as it measures cash generated from operations which the Company can use to fund working capital requirements and fund future growth initiatives.


News Provided by GlobeNewswire via QuoteMedia

The Conversation (0)

Compass Pathways to Participate in December Investor Conferences

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that members of the executive management team will participate in the following investor conferences in addition to hosting investor meetings:

  • 7 th Annual Evercore ISI HealthCONx Conference: Fireside chat at 10:25am ET on December 3, 2024
  • Piper Sandler 36 th Annual Healthcare Conference: Fireside chat at 3:30pm ET on December 4, 2024

A live audio webcast of these events will be accessible here for 30 days following the events.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Compass Pathways to participate in Stifel 2024 Healthcare Conference

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will present at the Stifel 2024 Healthcare Conference at 10:55 am ET on November 19, 2024.

A live audio webcast of the presentation will be accessible from the "Events" page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates

  • Top-line COMP005 data for COMP360 phase 3 pivotal program in treatment-resistant depression now expected in second quarter 2025
  • COMP006 data will now be announced after 26-week time point, expected in the second half of 2026
  • Strategic reorganization to focus all efforts on COMP360 program resulting in reduction of workforce of approximately 30%
  • Cash position of $207 million
  • Conference call October 31 at 8:00 am ET (12:00 pm UK)

Compass Pathways plc (Nasdaq: CMPS) ("Compass"), a biotechnology company dedicated to accelerating access to evidence-based innovation in mental health, today reported its financial results for the third quarter 2024 and an update on recent business progress.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Emyria Limited

Emyria and UWA in Partnership to Commercialise Novel Serotonin-Releasing Agents for Mental Health and Neurology

Emyria Limited (ASX: EMD) (“Emyria”, or the “Company”) has signed an exclusive licence agreement with UWA, granting worldwide rights to a rapidly growing portfolio of selective serotonin-releasing agents. (See Appendix for Key Commercial Terms). These novel compounds, realised through a UWA–Emyria research partnership launched in 2021,2 include potential next-generation treatments for mental health and neurological conditions such as PTSD and Parkinson’s disease.

Keep reading...Show less

Seelos Announces Second Postponement of its Annual Meeting of Stockholders

Seelos Therapeutics, Inc. (OTCQB: SEEL) ("Seelos"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that its 2024 Annual Meeting of Stockholders (the "Annual Meeting"), which was previously postponed to Friday, October 25, 2024 from its originally scheduled date of Friday, September 27, 2024 has been further postponed. The Annual Meeting is now scheduled to be held virtually, via live webcast at www.virtualshareholdermeeting.comSEEL2024 on Monday, November 25, 2024 at 8:00 a.m., Eastern Time . The record date for the Annual Meeting, August 19, 2024 is unchanged and applies to the postponed Annual Meeting.

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

Compass Pathways to Announce Third Quarter Financial Results on October 31, 2024

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the third quarter 2024 ending September 30, 2024, and provide an update on recent business developments, on October 31, 2024.

The management team will host a conference call at 8:00 am ET (12:00 pm UK) on October 31, 2024. To access the call, please register in advance here to obtain a local or toll-free phone number and your personal pin.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×